Wealth Management Associates, Inc. Sangamo Therapeutics, Inc Transaction History
Wealth Management Associates, Inc.
- $233 Billion
- Q1 2025
A detailed history of Wealth Management Associates, Inc. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wealth Management Associates, Inc. holds 228,400 shares of SGMO stock, worth $105,064. This represents 0.06% of its overall portfolio holdings.
Number of Shares
228,400
Previous 72,800
213.74%
Holding current value
$105,064
Previous $74.3 Million
101.71%
% of portfolio
0.06%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SGMO
# of Institutions
137Shares Held
51.2MCall Options Held
2.17MPut Options Held
1.82M-
Vanguard Group Inc Valley Forge, PA9.37MShares$4.31 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.87MShares$3.16 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$2.16 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.17MShares$1.46 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.28MShares$1.05 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $72M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...